147 related articles for article (PubMed ID: 11354308)
1. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells.
Engman L; Kandra T; Gallegos A; Williams R; Powis G
Anticancer Drug Des; 2000 Oct; 15(5):323-30. PubMed ID: 11354308
[TBL] [Abstract][Full Text] [Related]
2. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth.
McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA
J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants.
Engman L; Al-Maharik N; McNaughton M; Birmingham A; Powis G
Anticancer Drugs; 2003 Feb; 14(2):153-61. PubMed ID: 12569302
[TBL] [Abstract][Full Text] [Related]
5. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
[TBL] [Abstract][Full Text] [Related]
6. Selenium and the thioredoxin redox system: effects on cell growth and death.
Powis G; Gasdaska JR; Gasdaska PY; Berggren M; Kirkpatrick DL; Engman L; Cotgreave IA; Angulo M; Baker A
Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells.
Engman L; Al-Maharik N; McNaughton M; Birmingham A; Powis G
Bioorg Med Chem; 2003 Nov; 11(23):5091-100. PubMed ID: 14604673
[TBL] [Abstract][Full Text] [Related]
8. Gold(I) complex of N,N'-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties-potent tight-binding inhibition of thioredoxin reductase.
Yan K; Lok CN; Bierla K; Che CM
Chem Commun (Camb); 2010 Nov; 46(41):7691-3. PubMed ID: 20623063
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
10. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
Cheng Y; Qi Y
Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
[TBL] [Abstract][Full Text] [Related]
11. Insights into the strong in-vitro anticancer effects for bis(triphenylphosphane)iminium compounds having perchlorate, tetrafluoridoborate and bis(chlorido)argentate anions.
Folda A; Scalcon V; Ghazzali M; Jaafar MH; Khan RA; Casini A; Citta A; Bindoli A; Rigobello MP; Al-Farhan K; Alsalme A; Reedijk J
J Inorg Biochem; 2015 Dec; 153():346-354. PubMed ID: 26384162
[TBL] [Abstract][Full Text] [Related]
12. A sugar-modified phosphole gold complex with antiproliferative properties acting as a thioredoxin reductase inhibitor in MCF-7 cells.
Viry E; Battaglia E; Deborde V; Müller T; Réau R; Davioud-Charvet E; Bagrel D
ChemMedChem; 2008 Nov; 3(11):1667-70. PubMed ID: 18759235
[No Abstract] [Full Text] [Related]
13. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
15. New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead.
Wipf P; Hopkins TD; Jung JK; Rodriguez S; Birmingham A; Southwick EC; Lazo JS; Powis G
Bioorg Med Chem Lett; 2001 Oct; 11(19):2637-41. PubMed ID: 11551767
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of naphthazarin derivatives and identification of novel thioredoxin reductase inhibitor as potential anticancer agent.
Zhang J; Liu Y; Shi D; Hu G; Zhang B; Li X; Liu R; Han X; Yao X; Fang J
Eur J Med Chem; 2017 Nov; 140():435-447. PubMed ID: 28987605
[TBL] [Abstract][Full Text] [Related]
17. Cellular thioredoxin reductase activity is regulated by selenium.
Berggren M; Gallegos A; Gasdaska J; Powis G
Anticancer Res; 1997; 17(5A):3377-80. PubMed ID: 9413175
[TBL] [Abstract][Full Text] [Related]
18. Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents.
Gandin V; Fernandes AP
Molecules; 2015 Jul; 20(7):12732-56. PubMed ID: 26184149
[TBL] [Abstract][Full Text] [Related]
19. Strong inhibition of thioredoxin reductase by highly cytotoxic gold(I) complexes. DNA binding studies.
Ortego L; Cardoso F; Martins S; Fillat MF; Laguna A; Meireles M; Villacampa MD; Gimeno MC
J Inorg Biochem; 2014 Jan; 130():32-7. PubMed ID: 24157605
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
